Monopar Therapeutics (MNPR) › Shares OutstandingMonopar Therapeutics (MNPR) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2016: 02017: 9.29M2018: 9.29M2019: 10.59M2020: 11.45M2021: 12.60M2022: 12.95M2023: 2.98M2024: 6.10M2025: 6.69M6.69M2016Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY20256.69M+9.7%20246.10M+104.7%20232.98M-77.0%202212.95M+2.8%202112.60M+10.0%202011.45M+8.2%201910.59M+14.0%20189.29M+0.0%20179.29M—20160—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share